Alterations of gut microbiota in patients with active pulmonary tuberculosis in China: a pilot study
•A reduced diversity of gut microbiota was observed in tuberculosis (TB) patients.•TB patients had a low abundance of short-chain fatty acid-producing genera.•Active TB patients showed a raised abundance of several conditional pathogens.•Antibiotic use before TB diagnosis could alter the gut microbi...
Saved in:
Published in | International journal of infectious diseases Vol. 111; pp. 313 - 321 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
01.10.2021
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •A reduced diversity of gut microbiota was observed in tuberculosis (TB) patients.•TB patients had a low abundance of short-chain fatty acid-producing genera.•Active TB patients showed a raised abundance of several conditional pathogens.•Antibiotic use before TB diagnosis could alter the gut microbiota of patients.
Background: The aim of this study was to identify the differences in diversity, composition, and function of the gut microbiota between tuberculosis (TB) patients and healthy controls (HCs).
Methods: A cross-sectional study was conducted in three cities of China. Stool samples from 94 treatment-naive TB patients and 62 HCs were analyzed by 16S rRNA gene sequencing. TB patients were further divided into antibiotic-free and antibiotic-exposure according to their use of non-specific antibiotics before the TB diagnosis.
Results: Compared with HCs, antibiotic-free TB patients presented a different gut microbial community (P < 0.005) and decreased Shannon diversity (P < 0.005). Among TB patients, the relative abundances of short-chain fatty acid (SCFA)-producing genera such as Lachnospiraceae ND3007 group (log2(FC) = −2.74) were lower, while several conditional pathogen-related genera such as Enterococcus (log2(FC) = 12.05) and Rothia (log2(FC) = 6.322) were at higher levels. In addition, 41% of patients received antibiotics before TB diagnosis. Antibiotic exposure was correlated with an additional reduction in α diversity and depletion of SCFA-producing bacteria. Microbial functional analysis revealed that the biosynthesis capacity of amino acids and fatty acids was lower among TB patients compared to HCs.
Conclusions: Significant alterations in gut microbiota composition and metabolic pathways of TB patients were observed. Antibiotic exposure could alter the gut microbiota of TB patients, which should be considered in anti-TB treatment. |
---|---|
AbstractList | •A reduced diversity of gut microbiota was observed in tuberculosis (TB) patients.•TB patients had a low abundance of short-chain fatty acid-producing genera.•Active TB patients showed a raised abundance of several conditional pathogens.•Antibiotic use before TB diagnosis could alter the gut microbiota of patients.
Background: The aim of this study was to identify the differences in diversity, composition, and function of the gut microbiota between tuberculosis (TB) patients and healthy controls (HCs).
Methods: A cross-sectional study was conducted in three cities of China. Stool samples from 94 treatment-naive TB patients and 62 HCs were analyzed by 16S rRNA gene sequencing. TB patients were further divided into antibiotic-free and antibiotic-exposure according to their use of non-specific antibiotics before the TB diagnosis.
Results: Compared with HCs, antibiotic-free TB patients presented a different gut microbial community (P < 0.005) and decreased Shannon diversity (P < 0.005). Among TB patients, the relative abundances of short-chain fatty acid (SCFA)-producing genera such as Lachnospiraceae ND3007 group (log2(FC) = −2.74) were lower, while several conditional pathogen-related genera such as Enterococcus (log2(FC) = 12.05) and Rothia (log2(FC) = 6.322) were at higher levels. In addition, 41% of patients received antibiotics before TB diagnosis. Antibiotic exposure was correlated with an additional reduction in α diversity and depletion of SCFA-producing bacteria. Microbial functional analysis revealed that the biosynthesis capacity of amino acids and fatty acids was lower among TB patients compared to HCs.
Conclusions: Significant alterations in gut microbiota composition and metabolic pathways of TB patients were observed. Antibiotic exposure could alter the gut microbiota of TB patients, which should be considered in anti-TB treatment. Background: The aim of this study was to identify the differences in diversity, composition, and function of the gut microbiota between tuberculosis (TB) patients and healthy controls (HCs).Methods: A cross-sectional study was conducted in three cities of China. Stool samples from 94 treatment-naive TB patients and 62 HCs were analyzed by 16S rRNA gene sequencing. TB patients were further divided into antibiotic-free and antibiotic-exposure according to their use of non-specific antibiotics before the TB diagnosis.Results: Compared with HCs, antibiotic-free TB patients presented a different gut microbial community (P < 0.005) and decreased Shannon diversity (P < 0.005). Among TB patients, the relative abundances of short-chain fatty acid (SCFA)-producing genera such as Lachnospiraceae ND3007 group (log2(FC) = −2.74) were lower, while several conditional pathogen-related genera such as Enterococcus (log2(FC) = 12.05) and Rothia (log2(FC) = 6.322) were at higher levels. In addition, 41% of patients received antibiotics before TB diagnosis. Antibiotic exposure was correlated with an additional reduction in α diversity and depletion of SCFA-producing bacteria. Microbial functional analysis revealed that the biosynthesis capacity of amino acids and fatty acids was lower among TB patients compared to HCs.Conclusions: Significant alterations in gut microbiota composition and metabolic pathways of TB patients were observed. Antibiotic exposure could alter the gut microbiota of TB patients, which should be considered in anti-TB treatment. The aim of this study was to identify the differences in diversity, composition, and function of the gut microbiota between tuberculosis (TB) patients and healthy controls (HCs).BACKGROUNDThe aim of this study was to identify the differences in diversity, composition, and function of the gut microbiota between tuberculosis (TB) patients and healthy controls (HCs).A cross-sectional study was conducted in three cities of China. Stool samples from 94 treatment-naive TB patients and 62 HCs were analyzed by 16S rRNA gene sequencing. TB patients were further divided into antibiotic-free and antibiotic-exposure according to their use of non-specific antibiotics before the TB diagnosis.METHODSA cross-sectional study was conducted in three cities of China. Stool samples from 94 treatment-naive TB patients and 62 HCs were analyzed by 16S rRNA gene sequencing. TB patients were further divided into antibiotic-free and antibiotic-exposure according to their use of non-specific antibiotics before the TB diagnosis.Compared with HCs, antibiotic-free TB patients presented a different gut microbial community (P < 0.005) and decreased Shannon diversity (P < 0.005). Among TB patients, the relative abundances of short-chain fatty acid (SCFA)-producing genera such as Lachnospiraceae ND3007 group (log2(FC) = -2.74) were lower, while several conditional pathogen-related genera such as Enterococcus (log2(FC) = 12.05) and Rothia (log2(FC) = 6.322) were at higher levels. In addition, 41% of patients received antibiotics before TB diagnosis. Antibiotic exposure was correlated with an additional reduction in α diversity and depletion of SCFA-producing bacteria. Microbial functional analysis revealed that the biosynthesis capacity of amino acids and fatty acids was lower among TB patients compared to HCs.RESULTSCompared with HCs, antibiotic-free TB patients presented a different gut microbial community (P < 0.005) and decreased Shannon diversity (P < 0.005). Among TB patients, the relative abundances of short-chain fatty acid (SCFA)-producing genera such as Lachnospiraceae ND3007 group (log2(FC) = -2.74) were lower, while several conditional pathogen-related genera such as Enterococcus (log2(FC) = 12.05) and Rothia (log2(FC) = 6.322) were at higher levels. In addition, 41% of patients received antibiotics before TB diagnosis. Antibiotic exposure was correlated with an additional reduction in α diversity and depletion of SCFA-producing bacteria. Microbial functional analysis revealed that the biosynthesis capacity of amino acids and fatty acids was lower among TB patients compared to HCs.Significant alterations in gut microbiota composition and metabolic pathways of TB patients were observed. Antibiotic exposure could alter the gut microbiota of TB patients, which should be considered in anti-TB treatment.CONCLUSIONSSignificant alterations in gut microbiota composition and metabolic pathways of TB patients were observed. Antibiotic exposure could alter the gut microbiota of TB patients, which should be considered in anti-TB treatment. |
Author | Hu, Yi Wu, Meiying Chen, Cheng Xia, Fan Hu, Yue O.O. Shi, Wenpei Ning, Zhu Xu, Biao Prast-Nielsen, Stefanie |
Author_xml | – sequence: 1 givenname: Wenpei surname: Shi fullname: Shi, Wenpei organization: Department of Epidemiology, School of Public Health and Key Laboratory of Public Health Safety (Ministry of Education), Fudan University, Shanghai, China – sequence: 2 givenname: Yi surname: Hu fullname: Hu, Yi organization: Department of Epidemiology, School of Public Health and Key Laboratory of Public Health Safety (Ministry of Education), Fudan University, Shanghai, China – sequence: 3 givenname: Zhu surname: Ning fullname: Ning, Zhu organization: Zigong City Center for Disease Control and Prevention, Zigong City, Sichuan, China – sequence: 4 givenname: Fan surname: Xia fullname: Xia, Fan organization: Department of Tuberculosis, 905th Hospital of PLA Navy, Shanghai, China – sequence: 5 givenname: Meiying surname: Wu fullname: Wu, Meiying organization: Department of Clinical Laboratory, The Fifth People's Hospital of Suzhou(The Affiliated Infectious Diseases Hospital of Soochow University), Suzhou City, Jiangsu, China – sequence: 6 givenname: Yue O.O. surname: Hu fullname: Hu, Yue O.O. organization: Center for Translational Microbiome Research (CTMR), Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden – sequence: 7 givenname: Cheng surname: Chen fullname: Chen, Cheng organization: Jiangsu Provincial Centre for Disease Control and Prevention, Nanjing, Jiangsu, China – sequence: 8 givenname: Stefanie orcidid: 0000-0001-5877-7988 surname: Prast-Nielsen fullname: Prast-Nielsen, Stefanie organization: Center for Translational Microbiome Research (CTMR), Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden – sequence: 9 givenname: Biao surname: Xu fullname: Xu, Biao email: bxu@shmu.edu.cn organization: Department of Epidemiology, School of Public Health and Key Laboratory of Public Health Safety (Ministry of Education), Fudan University, Shanghai, China |
BackLink | http://kipublications.ki.se/Default.aspx?queryparsed=id:147831417$$DView record from Swedish Publication Index |
BookMark | eNqFkUtP3TAQhaOKSgXaP9CVl90ktZ2Xg7pBV30gIXXTri3HGcME3zi1HdD99zg3sIAFXXk0Pt-Z0Zyz7GRyE2TZZ0YLRlnzdSxwxKHglLOCioI21bvslIlW5GXN2EmqOWV51zL-ITsLYaSUVk0jTrPh0kbwKqKbAnGG3CyR7FF716OLiuBE5vQJUwzkAeMtUTriPZB5sXs3KX8gcenB68W6gGGV725xUhdEkRmtiyTEZTh8zN4bZQN8enrPs78_vv_Z_cqvf_-82l1e57ouecwrykSpa6464EoDHwTrSl5By0F1mpu2Y22rWw2lMWIAbVjd8aEuy6EBUwlRnmdXm-_g1Chnj_u0oXQK5bHh_I1UPqK2IEHUoleGcqpVVXdMqKoqexi4qVNHmOSVb17hAealf-H21LpLFchE8-PsL5t-9u7fAiHKPQYN1qoJ3BIkr5uuYY3gq1Rs0nTmEDwYqTEeI4heoZWMyjVUOco1VLmGKqmQKdSE8lfo815vQt82CNLt7xG8DDpFqmFADzqm4-Db-MUrXFucUCt7B4f_wY-9Q9MY |
CitedBy_id | crossref_primary_10_1080_14787210_2023_2162879 crossref_primary_10_3389_fimmu_2024_1442095 crossref_primary_10_1007_s40121_023_00880_4 crossref_primary_10_1016_j_mucimm_2024_12_013 crossref_primary_10_1016_j_nano_2023_102653 crossref_primary_10_1016_j_tjnut_2024_08_005 crossref_primary_10_1016_j_microb_2024_100230 crossref_primary_10_1038_s41598_025_87160_y crossref_primary_10_1007_s00203_024_03843_6 crossref_primary_10_1007_s12088_024_01433_0 crossref_primary_10_1038_s41598_023_34765_w crossref_primary_10_3389_fcimb_2023_1149679 crossref_primary_10_1016_j_diagmicrobio_2024_116291 crossref_primary_10_1186_s12967_025_06190_2 crossref_primary_10_3389_fmicb_2023_1236348 crossref_primary_10_3389_fmicb_2023_1237998 crossref_primary_10_3390_clinpract14010017 crossref_primary_10_3390_ani13193104 crossref_primary_10_58838_2075_1230_2024_102_2_86_96 crossref_primary_10_3389_fcimb_2024_1331521 crossref_primary_10_1016_j_foodcont_2024_110834 |
Cites_doi | 10.1128/mBio.01693-15 10.1093/bioinformatics/btp616 10.1093/nar/gks1219 10.1124/dmd.115.065714 10.1038/nrmicro.2016.142 10.1093/jac/14.suppl_B.317 10.1038/nm.3444 10.1186/s13073-016-0307-y 10.1038/s41590-019-0451-9 10.1186/s40168-017-0286-2 10.1093/bioinformatics/btu494 10.1038/nchembio.1864 10.1111/1462-2920.14015 10.1097/MOG.0000000000000139 10.3389/fphys.2017.00822 10.1007/s12199-011-0219-9 10.1007/s10096-012-1787-3 10.1080/03602532.2018.1497647 10.1016/j.jinf.2018.08.006 10.1186/s12890-019-0981-9 10.1186/s12889-015-1922-z 10.1371/journal.pone.0007401 10.1177/1756283X13482996 10.1038/nmeth.3869 10.1097/MD.0000000000003587 10.3389/fcimb.2019.00090 10.1111/j.1440-1843.2010.01739.x 10.1186/1741-7015-11-156 10.1038/nature12506 10.1038/cmi.2017.88 |
ContentType | Journal Article |
Copyright | 2021 The Author(s) Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. |
Copyright_xml | – notice: 2021 The Author(s) – notice: Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. |
DBID | 6I. AAFTH AAYXX CITATION 7X8 ADTPV AOWAS D8T ZZAVC DOA |
DOI | 10.1016/j.ijid.2021.08.064 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef MEDLINE - Academic SwePub SwePub Articles SWEPUB Freely available online SwePub Articles full text DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1878-3511 |
EndPage | 321 |
ExternalDocumentID | oai_doaj_org_article_e858baf020ca45918a443bed2f50ca8f oai_swepub_ki_se_459288 10_1016_j_ijid_2021_08_064 S1201971221006974 |
GroupedDBID | --- --K .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 29J 3O- 4.4 457 4G. 53G 5GY 5VS 7-5 71M 7X7 88E 8C1 8FI 8FJ 8FQ 8R4 8R5 AAEDW AAFWJ AAIKJ AALRI AAQFI AAQXK AARKO AAXUO AAYWO ABBQC ABFRF ABMAC ABUWG ABWVN ACGFO ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADVLN AEFWE AEKER AENEX AEUPX AEVXI AEXQZ AFJKZ AFKRA AFPKN AFPUW AFRHN AFTJW AGEKW AGHFR AGQPQ AGYEJ AHMBA AIGII AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APXCP ASPBG AVWKF AZFZN BAWUL BCNDV BENPR BPHCQ BR6 BVXVI CCPQU CS3 DIK DU5 DWQXO E3Z EBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FNPLU FYUFA G-Q GBLVA GROUPED_DOAJ GX1 HMCUK HVGLF HZ~ IHE IXB J1W KQ8 M1P M3C M3G M41 MO0 N9A O-L O9- OD- OK1 OO. OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO Q2X Q38 QTD R2- ROL RPZ RWL RXW SDF SDG SEL SES SEW SSZ TAE UKHRP UNMZH Z5R 0SF 3V. 6I. AACTN AAFTH ABVKL AFCTW NCXOZ RIG AAYXX ALIPV CITATION 7X8 ADTPV AOWAS D8T ZZAVC |
ID | FETCH-LOGICAL-c532t-40183c52a9e2ace2d819324e72ea9c2f79177c7ce3ff8decf1592d533d6ef4883 |
IEDL.DBID | .~1 |
ISSN | 1201-9712 1878-3511 |
IngestDate | Wed Aug 27 01:01:23 EDT 2025 Mon Aug 25 03:39:21 EDT 2025 Fri Jul 11 01:33:02 EDT 2025 Tue Jul 01 04:30:08 EDT 2025 Thu Apr 24 22:59:29 EDT 2025 Fri Feb 23 02:42:41 EST 2024 Tue Aug 26 16:32:05 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Gut microbiota 16S rRNA gene sequencing Antibiotic Tuberculosis |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c532t-40183c52a9e2ace2d819324e72ea9c2f79177c7ce3ff8decf1592d533d6ef4883 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-5877-7988 |
OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1201971221006974 |
PQID | 2569616828 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_e858baf020ca45918a443bed2f50ca8f swepub_primary_oai_swepub_ki_se_459288 proquest_miscellaneous_2569616828 crossref_citationtrail_10_1016_j_ijid_2021_08_064 crossref_primary_10_1016_j_ijid_2021_08_064 elsevier_sciencedirect_doi_10_1016_j_ijid_2021_08_064 elsevier_clinicalkey_doi_10_1016_j_ijid_2021_08_064 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-10-01 |
PublicationDateYYYYMMDD | 2021-10-01 |
PublicationDate_xml | – month: 10 year: 2021 text: 2021-10-01 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | International journal of infectious diseases |
PublicationYear | 2021 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Maji, Misra, Dhakan, Gupta, Mahato, Saxena (bib0022) 2018; 20 Paula, Elena, Gustavo, Jorge, Vanessa, Ismael (bib0029) 2016; 6 Shi, Hu, Zheng, Ning, Wu, Xia (bib0033) 2019; 19 Trompette, Gollwitzer, Yadava, Sichelstiel, Sprenger, Ngom-Bru (bib0037) 2014; 20 Negatu, Liu, Zimmerman, Kaya, Dartois, Aldrich (bib0025) 2018; 62(3) Wang, Qian (bib0038) 2009; 4 Liu, Liu, Ge (bib0019) 2017; 14 Robinson, McCarthy, Smyth (bib0031) 2010; 26 Eribo, du Plessis, Ozturk, Guler, Walzl, Chegou (bib0012) 2019 Sabawoon, Sato, Kobayashi (bib0032) 2012; 17 Dheda, Schwander, Zhu, Van Zylsmit, Zhang (bib0009) 2010; 15 Quast, Pruesse, Yilmaz, Gerken, Schweer, Yarza (bib0030) 2012; 41 Wypych, Wickramasinghe, Marsland (bib0039) 2019; 20 Zaura, Brandt, Mattos, Buijs, Crielaard (bib0040) 2015; 6 Sunakawa, Akita, Iwata, Sato (bib0035) 1984; 14 Guinane, Cotter (bib0013) 2013; 6 Zhang, Zhang, Wang (bib0041) 2018; 50 Hu, Yang, Liu, Dong, Sun, Zhu (bib0015) 2018; 78 Dubourg, Lagier, Armougom, Robert, Raoult (bib0011) 2013; 32 Hu, Feng, Wu, Liu, Zhang, Hao (bib0014) 2019; 9 Li, Ehiri, Tang, Li, Bian, Lin (bib0018) 2013; 11 Parks, Tyson, Hugenholtz, Beiko (bib42) 2014; 30 Osei, Akweongo, Binka (bib0028) 2015; 15 World Health Organization (bib0027) 2019 Namasivayam, Maiga, Yuan, Thovarai, Costa, Mittereder (bib0024) 2017; 5 Swanson (bib0036) 2015; 43 Oksanen, Kindt, Legendre, O'Hara, Stevens, Oksanen (bib0026) 2007; 10 Lloyd-Price, Abu-Ali, Huttenhower (bib0020) 2016; 8 Azad, Kozyrskyj (bib0001) 2011 Li, Song, Yang, Chen, Gong, Yin (bib0017) 2016; 95 Le Chatelier, Nielsen, Qin, Prifti, Hildebrand, Falony (bib0016) 2013; 500 Shreiner AB, Kao JY, Young VB. 2021 The gut microbiome in health and in disease. Curr Opin Gastroen;31(1):69-75. Devlin, Fischbach (bib0008) 2015; 11 Bolyen, Rideout, Dillon, Bokulich, Abnet, Al-Ghalith (bib0002) 2018 Douglas, Maffei, Zaneveld, Yurgel, Brown, Taylor (bib0010) 2019 Budden, Gellatly, Wood, Cooper, Morrison, Hugenholtz (bib0003) 2017; 15 Craig, Bettinson, Sabin, Gillespie, Lipman (bib0006) 2009; 13 Luo, Liu, Wu, Luo, Sun, Zheng (bib0021) 2017; 8 Callahan, McMurdie, Rosen, Han, Johnson, Holmes (bib0004) 2016; 13 Mayhew, Devos, Lambert, Brown, Clarke, Kim (bib0023) 2018; 73 Daniels, Kwan, Pai, Das (bib0007) 2019; 16 Budden (10.1016/j.ijid.2021.08.064_bib0003) 2017; 15 Osei (10.1016/j.ijid.2021.08.064_bib0028) 2015; 15 Quast (10.1016/j.ijid.2021.08.064_bib0030) 2012; 41 Eribo (10.1016/j.ijid.2021.08.064_bib0012) 2019 Daniels (10.1016/j.ijid.2021.08.064_bib0007) 2019; 16 Shi (10.1016/j.ijid.2021.08.064_bib0033) 2019; 19 Li (10.1016/j.ijid.2021.08.064_bib0017) 2016; 95 World Health Organization (10.1016/j.ijid.2021.08.064_bib0027) 2019 Liu (10.1016/j.ijid.2021.08.064_bib0019) 2017; 14 Le Chatelier (10.1016/j.ijid.2021.08.064_bib0016) 2013; 500 Paula (10.1016/j.ijid.2021.08.064_bib0029) 2016; 6 Dheda (10.1016/j.ijid.2021.08.064_bib0009) 2010; 15 Zhang (10.1016/j.ijid.2021.08.064_bib0041) 2018; 50 Sabawoon (10.1016/j.ijid.2021.08.064_bib0032) 2012; 17 Mayhew (10.1016/j.ijid.2021.08.064_bib0023) 2018; 73 Negatu (10.1016/j.ijid.2021.08.064_bib0025) 2018; 62(3) Trompette (10.1016/j.ijid.2021.08.064_bib0037) 2014; 20 Guinane (10.1016/j.ijid.2021.08.064_bib0013) 2013; 6 Zaura (10.1016/j.ijid.2021.08.064_bib0040) 2015; 6 Oksanen (10.1016/j.ijid.2021.08.064_bib0026) 2007; 10 Maji (10.1016/j.ijid.2021.08.064_bib0022) 2018; 20 Swanson (10.1016/j.ijid.2021.08.064_bib0036) 2015; 43 Devlin (10.1016/j.ijid.2021.08.064_bib0008) 2015; 11 Luo (10.1016/j.ijid.2021.08.064_bib0021) 2017; 8 Parks (10.1016/j.ijid.2021.08.064_bib42) 2014; 30 Wang (10.1016/j.ijid.2021.08.064_bib0038) 2009; 4 Hu (10.1016/j.ijid.2021.08.064_bib0014) 2019; 9 Azad (10.1016/j.ijid.2021.08.064_bib0001) 2011 Bolyen (10.1016/j.ijid.2021.08.064_bib0002) 2018 Wypych (10.1016/j.ijid.2021.08.064_bib0039) 2019; 20 Robinson (10.1016/j.ijid.2021.08.064_bib0031) 2010; 26 Lloyd-Price (10.1016/j.ijid.2021.08.064_bib0020) 2016; 8 Callahan (10.1016/j.ijid.2021.08.064_bib0004) 2016; 13 Dubourg (10.1016/j.ijid.2021.08.064_bib0011) 2013; 32 Li (10.1016/j.ijid.2021.08.064_bib0018) 2013; 11 Sunakawa (10.1016/j.ijid.2021.08.064_bib0035) 1984; 14 Namasivayam (10.1016/j.ijid.2021.08.064_bib0024) 2017; 5 Douglas (10.1016/j.ijid.2021.08.064_bib0010) 2019 Hu (10.1016/j.ijid.2021.08.064_bib0015) 2018; 78 10.1016/j.ijid.2021.08.064_bib0034 Craig (10.1016/j.ijid.2021.08.064_bib0006) 2009; 13 |
References_xml | – volume: 11 start-page: 156 year: 2013 ident: bib0018 article-title: Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis publication-title: Bmc Med – volume: 62(3) year: 2018 ident: bib0025 article-title: Whole-cell screen of fragment library identifies gut microbiota metabolite indole propionic acid as antitubercular publication-title: Antimicrobial Agents & Chemotherapy:AAC – year: 2019 ident: bib0010 article-title: PICRUSt2: an improved and extensible approach for metagenome inference publication-title: BioRxiv – volume: 13 start-page: 208 year: 2009 end-page: 213 ident: bib0006 article-title: Think TB! is the diagnosis of pulmonary tuberculosis delayed by the use of antibiotics? publication-title: Int J Tuberc Lung Dis – volume: 500 start-page: 541 year: 2013 end-page: 546 ident: bib0016 article-title: Richness of human gut microbiome correlates with metabolic markers publication-title: Nature – volume: 95 start-page: e3587 year: 2016 ident: bib0017 article-title: A systematic review of antibiotic prescription associated with upper respiratory tract infections in China publication-title: Medicine – volume: 10 start-page: 631 year: 2007 end-page: 637 ident: bib0026 article-title: The vegan package publication-title: Community ecology package – volume: 26 start-page: 139 year: 2010 end-page: 140 ident: bib0031 article-title: edgeR: a Bioconductor package for differential expression analysis of digital gene expression data publication-title: Bioinformatics – reference: Shreiner AB, Kao JY, Young VB. 2021 The gut microbiome in health and in disease. Curr Opin Gastroen;31(1):69-75. – year: 2018 ident: bib0002 article-title: QIIME 2: Reproducible, interactive, scalable, and extensible microbiome data science publication-title: PeerJ Preprints; – volume: 19 start-page: 211 year: 2019 ident: bib0033 article-title: Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study publication-title: Bmc Pulm Med – start-page: 2012 year: 2011 ident: bib0001 article-title: Perinatal programming of asthma: the role of gut microbiota publication-title: Clinical and Developmental Immunology – volume: 14 start-page: 963 year: 2017 end-page: 975 ident: bib0019 article-title: Innate immunity in tuberculosis: host defense vs pathogen evasion publication-title: Cell Mol Immunol – year: 2019 ident: bib0027 publication-title: Global tuberculosis report 2019 – volume: 6 start-page: 1482 year: 2016 ident: bib0029 article-title: Oral administration of heat-killed Mycobacterium manresensis delays progression toward active Tuberculosis in C3HeB/FeJ Mice publication-title: Front Microbiol – volume: 9 start-page: 90 year: 2019 ident: bib0014 article-title: The gut microbiome signatures discriminate healthy from Pulmonary Tuberculosis patients publication-title: Front Cell Infect Microbiol – year: 2019 ident: bib0012 article-title: The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty? publication-title: Cell Mol Life Sci – volume: 78 start-page: 317 year: 2018 end-page: 322 ident: bib0015 article-title: Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs publication-title: J Infection – volume: 4 start-page: e7401 year: 2009 ident: bib0038 article-title: Conservative fragments in bacterial 16S rRNA genes and primer design for 16S ribosomal DNA amplicons in metagenomic studies publication-title: Plos One – volume: 16 year: 2019 ident: bib0007 article-title: Lessons on the quality of tuberculosis diagnosis from standardized patients in China, India, Kenya, and South Africa publication-title: J Clin Tuberc Other Mycobact Dis – volume: 15 start-page: 721 year: 2015 ident: bib0028 article-title: Factors associated with DELAY in diagnosis among tuberculosis patients in Hohoe Municipality publication-title: Ghana. Bmc Public Health – volume: 20 start-page: 159 year: 2014 ident: bib0037 article-title: Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis publication-title: Nat Med – volume: 17 start-page: 53 year: 2012 end-page: 61 ident: bib0032 article-title: Delay in the treatment of pulmonary tuberculosis: a report from Afghanistan publication-title: Environ Health Prev – volume: 20 start-page: 402 year: 2018 end-page: 419 ident: bib0022 article-title: Gut microbiome contributes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers publication-title: Environ Microbiol – volume: 14 start-page: 317 year: 1984 end-page: 324 ident: bib0035 article-title: The influence of cefotaxime on intestinal flora and bleeding diathesis in infants and neonates, compared with other -lactams publication-title: J Antimicrob Chemoth – volume: 41 start-page: D590 year: 2012 end-page: D5D6 ident: bib0030 article-title: The SILVA ribosomal RNA gene database project: improved data processing and web-based tools publication-title: Nucleic Acids Res – volume: 8 start-page: 822 year: 2017 ident: bib0021 article-title: Alternation of gut microbiota in patients with Pulmonary Tuberculosis publication-title: Front Physiol – volume: 43 start-page: 1499 year: 2015 end-page: 1504 ident: bib0036 article-title: Drug metabolism by the host and gut microbiota: a partnership or rivalry? publication-title: Drug Metab Dispos – volume: 6 year: 2015 ident: bib0040 article-title: Same exposure but two radically different responses to antibiotics: resilience of the salivary microbiome versus long-term microbial shifts in feces publication-title: Mbio – volume: 13 start-page: 581 year: 2016 end-page: 583 ident: bib0004 article-title: DADA2: high-resolution sample inference from Illumina amplicon data publication-title: Nat Methods – volume: 15 start-page: 433 year: 2010 end-page: 450 ident: bib0009 article-title: The immunology of tuberculosis: from bench to bedside publication-title: Respirology – volume: 11 start-page: 685 year: 2015 end-page: 690 ident: bib0008 article-title: A biosynthetic pathway for a prominent class of microbiota-derived bile acids publication-title: Nat Chem Biol – volume: 8 start-page: 51 year: 2016 ident: bib0020 article-title: The healthy human microbiome publication-title: Genome Med – volume: 73 start-page: 422 year: 2018 end-page: 430 ident: bib0023 publication-title: Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations – volume: 6 start-page: 295 year: 2013 end-page: 308 ident: bib0013 article-title: Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ publication-title: Therap Adv Gastroenterol – volume: 15 start-page: 55 year: 2017 ident: bib0003 article-title: Emerging pathogenic links between microbiota and the gut–lung axis publication-title: Nat Rev Microbiol – volume: 32 year: 2013 ident: bib0011 article-title: The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics publication-title: Eur J Clin Microbiol – volume: 5 start-page: 71 year: 2017 ident: bib0024 article-title: Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy publication-title: Microbiome – volume: 30 start-page: 3123 year: 2014 end-page: 3124 ident: bib42 publication-title: Bioinformatics – volume: 20 start-page: 1279 year: 2019 end-page: 1290 ident: bib0039 article-title: The influence of the microbiome on respiratory health publication-title: Nat Immunol – volume: 50 start-page: 357 year: 2018 end-page: 368 ident: bib0041 article-title: Gut microbiota modulates drug pharmacokinetics publication-title: Drug Metab Rev – volume: 6 issue: 6 year: 2015 ident: 10.1016/j.ijid.2021.08.064_bib0040 article-title: Same exposure but two radically different responses to antibiotics: resilience of the salivary microbiome versus long-term microbial shifts in feces publication-title: Mbio doi: 10.1128/mBio.01693-15 – volume: 26 start-page: 139 issue: 1 year: 2010 ident: 10.1016/j.ijid.2021.08.064_bib0031 article-title: edgeR: a Bioconductor package for differential expression analysis of digital gene expression data publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp616 – volume: 41 start-page: D590 issue: D1 year: 2012 ident: 10.1016/j.ijid.2021.08.064_bib0030 article-title: The SILVA ribosomal RNA gene database project: improved data processing and web-based tools publication-title: Nucleic Acids Res doi: 10.1093/nar/gks1219 – volume: 43 start-page: 1499 issue: 10 year: 2015 ident: 10.1016/j.ijid.2021.08.064_bib0036 article-title: Drug metabolism by the host and gut microbiota: a partnership or rivalry? publication-title: Drug Metab Dispos doi: 10.1124/dmd.115.065714 – volume: 15 start-page: 55 issue: 1 year: 2017 ident: 10.1016/j.ijid.2021.08.064_bib0003 article-title: Emerging pathogenic links between microbiota and the gut–lung axis publication-title: Nat Rev Microbiol doi: 10.1038/nrmicro.2016.142 – volume: 14 start-page: 317 year: 1984 ident: 10.1016/j.ijid.2021.08.064_bib0035 article-title: The influence of cefotaxime on intestinal flora and bleeding diathesis in infants and neonates, compared with other -lactams publication-title: J Antimicrob Chemoth doi: 10.1093/jac/14.suppl_B.317 – volume: 20 start-page: 159 issue: 2 year: 2014 ident: 10.1016/j.ijid.2021.08.064_bib0037 article-title: Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis publication-title: Nat Med doi: 10.1038/nm.3444 – volume: 8 start-page: 51 issue: 1 year: 2016 ident: 10.1016/j.ijid.2021.08.064_bib0020 article-title: The healthy human microbiome publication-title: Genome Med doi: 10.1186/s13073-016-0307-y – volume: 20 start-page: 1279 issue: 10 year: 2019 ident: 10.1016/j.ijid.2021.08.064_bib0039 article-title: The influence of the microbiome on respiratory health publication-title: Nat Immunol doi: 10.1038/s41590-019-0451-9 – volume: 5 start-page: 71 issue: 1 year: 2017 ident: 10.1016/j.ijid.2021.08.064_bib0024 article-title: Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy publication-title: Microbiome doi: 10.1186/s40168-017-0286-2 – volume: 30 start-page: 3123 year: 2014 ident: 10.1016/j.ijid.2021.08.064_bib42 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btu494 – volume: 16 year: 2019 ident: 10.1016/j.ijid.2021.08.064_bib0007 article-title: Lessons on the quality of tuberculosis diagnosis from standardized patients in China, India, Kenya, and South Africa publication-title: J Clin Tuberc Other Mycobact Dis – volume: 11 start-page: 685 issue: 9 year: 2015 ident: 10.1016/j.ijid.2021.08.064_bib0008 article-title: A biosynthetic pathway for a prominent class of microbiota-derived bile acids publication-title: Nat Chem Biol doi: 10.1038/nchembio.1864 – volume: 20 start-page: 402 issue: 1 year: 2018 ident: 10.1016/j.ijid.2021.08.064_bib0022 article-title: Gut microbiome contributes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers publication-title: Environ Microbiol doi: 10.1111/1462-2920.14015 – ident: 10.1016/j.ijid.2021.08.064_bib0034 doi: 10.1097/MOG.0000000000000139 – volume: 8 start-page: 822 year: 2017 ident: 10.1016/j.ijid.2021.08.064_bib0021 article-title: Alternation of gut microbiota in patients with Pulmonary Tuberculosis publication-title: Front Physiol doi: 10.3389/fphys.2017.00822 – volume: 17 start-page: 53 issue: 1 year: 2012 ident: 10.1016/j.ijid.2021.08.064_bib0032 article-title: Delay in the treatment of pulmonary tuberculosis: a report from Afghanistan publication-title: Environ Health Prev doi: 10.1007/s12199-011-0219-9 – start-page: 2012 year: 2011 ident: 10.1016/j.ijid.2021.08.064_bib0001 article-title: Perinatal programming of asthma: the role of gut microbiota publication-title: Clinical and Developmental Immunology – volume: 32 issue: 5 year: 2013 ident: 10.1016/j.ijid.2021.08.064_bib0011 article-title: The gut microbiota of a patient with resistant tuberculosis is more comprehensively studied by culturomics than by metagenomics publication-title: Eur J Clin Microbiol doi: 10.1007/s10096-012-1787-3 – volume: 13 start-page: 208 issue: 2 year: 2009 ident: 10.1016/j.ijid.2021.08.064_bib0006 article-title: Think TB! is the diagnosis of pulmonary tuberculosis delayed by the use of antibiotics? publication-title: Int J Tuberc Lung Dis – volume: 50 start-page: 357 issue: 3 year: 2018 ident: 10.1016/j.ijid.2021.08.064_bib0041 article-title: Gut microbiota modulates drug pharmacokinetics publication-title: Drug Metab Rev doi: 10.1080/03602532.2018.1497647 – volume: 78 start-page: 317 issue: 4 year: 2018 ident: 10.1016/j.ijid.2021.08.064_bib0015 article-title: Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs publication-title: J Infection doi: 10.1016/j.jinf.2018.08.006 – year: 2019 ident: 10.1016/j.ijid.2021.08.064_bib0012 article-title: The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty? publication-title: Cell Mol Life Sci – year: 2019 ident: 10.1016/j.ijid.2021.08.064_bib0010 article-title: PICRUSt2: an improved and extensible approach for metagenome inference publication-title: BioRxiv – volume: 19 start-page: 211 issue: 1 year: 2019 ident: 10.1016/j.ijid.2021.08.064_bib0033 article-title: Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study publication-title: Bmc Pulm Med doi: 10.1186/s12890-019-0981-9 – volume: 62(3) year: 2018 ident: 10.1016/j.ijid.2021.08.064_bib0025 article-title: Whole-cell screen of fragment library identifies gut microbiota metabolite indole propionic acid as antitubercular publication-title: Antimicrobial Agents & Chemotherapy:AAC – volume: 15 start-page: 721 issue: 1 year: 2015 ident: 10.1016/j.ijid.2021.08.064_bib0028 article-title: Factors associated with DELAY in diagnosis among tuberculosis patients in Hohoe Municipality publication-title: Ghana. Bmc Public Health doi: 10.1186/s12889-015-1922-z – volume: 4 start-page: e7401 issue: 10 year: 2009 ident: 10.1016/j.ijid.2021.08.064_bib0038 article-title: Conservative fragments in bacterial 16S rRNA genes and primer design for 16S ribosomal DNA amplicons in metagenomic studies publication-title: Plos One doi: 10.1371/journal.pone.0007401 – volume: 6 start-page: 295 issue: 4 year: 2013 ident: 10.1016/j.ijid.2021.08.064_bib0013 article-title: Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ publication-title: Therap Adv Gastroenterol doi: 10.1177/1756283X13482996 – volume: 6 start-page: 1482 year: 2016 ident: 10.1016/j.ijid.2021.08.064_bib0029 article-title: Oral administration of heat-killed Mycobacterium manresensis delays progression toward active Tuberculosis in C3HeB/FeJ Mice publication-title: Front Microbiol – volume: 73 start-page: 422 issue: 5 year: 2018 ident: 10.1016/j.ijid.2021.08.064_bib0023 publication-title: Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations – volume: 13 start-page: 581 issue: 7 year: 2016 ident: 10.1016/j.ijid.2021.08.064_bib0004 article-title: DADA2: high-resolution sample inference from Illumina amplicon data publication-title: Nat Methods doi: 10.1038/nmeth.3869 – volume: 95 start-page: e3587 issue: 19 year: 2016 ident: 10.1016/j.ijid.2021.08.064_bib0017 article-title: A systematic review of antibiotic prescription associated with upper respiratory tract infections in China publication-title: Medicine doi: 10.1097/MD.0000000000003587 – year: 2018 ident: 10.1016/j.ijid.2021.08.064_bib0002 article-title: QIIME 2: Reproducible, interactive, scalable, and extensible microbiome data science publication-title: PeerJ Preprints; – volume: 9 start-page: 90 year: 2019 ident: 10.1016/j.ijid.2021.08.064_bib0014 article-title: The gut microbiome signatures discriminate healthy from Pulmonary Tuberculosis patients publication-title: Front Cell Infect Microbiol doi: 10.3389/fcimb.2019.00090 – volume: 15 start-page: 433 issue: 3 year: 2010 ident: 10.1016/j.ijid.2021.08.064_bib0009 article-title: The immunology of tuberculosis: from bench to bedside publication-title: Respirology doi: 10.1111/j.1440-1843.2010.01739.x – volume: 11 start-page: 156 year: 2013 ident: 10.1016/j.ijid.2021.08.064_bib0018 article-title: Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis publication-title: Bmc Med doi: 10.1186/1741-7015-11-156 – volume: 500 start-page: 541 issue: 7464 year: 2013 ident: 10.1016/j.ijid.2021.08.064_bib0016 article-title: Richness of human gut microbiome correlates with metabolic markers publication-title: Nature doi: 10.1038/nature12506 – volume: 14 start-page: 963 issue: 12 year: 2017 ident: 10.1016/j.ijid.2021.08.064_bib0019 article-title: Innate immunity in tuberculosis: host defense vs pathogen evasion publication-title: Cell Mol Immunol doi: 10.1038/cmi.2017.88 – volume: 10 start-page: 631 year: 2007 ident: 10.1016/j.ijid.2021.08.064_bib0026 article-title: The vegan package publication-title: Community ecology package – year: 2019 ident: 10.1016/j.ijid.2021.08.064_bib0027 |
SSID | ssj0004668 |
Score | 2.4151387 |
Snippet | •A reduced diversity of gut microbiota was observed in tuberculosis (TB) patients.•TB patients had a low abundance of short-chain fatty acid-producing... The aim of this study was to identify the differences in diversity, composition, and function of the gut microbiota between tuberculosis (TB) patients and... Background: The aim of this study was to identify the differences in diversity, composition, and function of the gut microbiota between tuberculosis (TB)... |
SourceID | doaj swepub proquest crossref elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 313 |
SubjectTerms | 16S rRNA gene sequencing Antibiotic Gut microbiota Tuberculosis |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwELUQB4RUVXShYoEiV0JcUNSN4yQON0BdrSq1J1biZnmdcRVIk9VucuDfM_7IavcCl94iy07izNjzxpl5Q8jVhGmuiskkAlHwiCMEiIQAKxA0xiaDCRgXIPsnm835r6f0aavUl40J8_TA_sP9AJGKhTKIarTiaRELxXmygJKZFFuEsbsv2rzBmdpkRPokODRvUZHHLKTL-Miu6rmyHKEskHfyHZPkmPt3LNM28txmE3UWaHpEPgfoSO_8K38he9CMyMHv8HN8RD75IzjqM4uOSXlXO8pkq1i0NfRv39F_lSde6hStGhpIVdfUnsZS5bY-uuxrVE21eqVdv4CV7ut2Xa1td1dr-5YquqzqtqOOmfaEzKc_Hx9mUSiqEOk0YR36i7iIdcpUAUxpYKWwEI5DzkAVmpkc_bdc5xoSY0QJ2iDeYSWCwjIDg6s9-Ur2m7aBU0IBsQ16UyrjKuEJN6pE9MEUyivORQHlmMTDd5U6MI7bwhe1HELLnqWVhbSykLYaZsbH5GYzZun5Nt7tfW_FtelpubJdA2qQDBokP9KgMUkGYcshHRU3ULxR9e6j082oAFY8CPlw3PdBnySuZPt7RjXQ9muJ4LPI4gxd4DG59oq2M7HQ9IJXIHEiTIiz_zH_c3Jo389HKF6Q_W7VwzdEWt3i0i2qN0rUJa0 priority: 102 providerName: Directory of Open Access Journals |
Title | Alterations of gut microbiota in patients with active pulmonary tuberculosis in China: a pilot study |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1201971221006974 https://dx.doi.org/10.1016/j.ijid.2021.08.064 https://www.proquest.com/docview/2569616828 http://kipublications.ki.se/Default.aspx?queryparsed=id:147831417 https://doaj.org/article/e858baf020ca45918a443bed2f50ca8f |
Volume | 111 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELamPSAkhMYAURiTkRAvKDRxnMThbZuYBggkBJP6ZrnOefIISdUmD7zwt3P-kap9GRIvUWudWyd39n3n3H0m5HXKNFd1miYgap5whACJEOAUgs7YlJCC8QmyX8ura_5pUSwOyMVUC-PSKuPaH9Z0v1rHlnl8mvOVtfPvGfquusoYBi1pibDYVbDzyln5uz_ZTm1kKIdD4cRJx8KZkONlb61jC2WRxpPvOSfP4b_no3Yx6C6vqPdFl0fkYQSR9CyM8xE5gO6Y3PsSX5MfkwdhM46GGqPHpDlrPXmyMzHaG3ozDvSXDRRMg6K2o5FedUPdvixVfhGkq7FFI1Xr33QYl7DWY9tv7MaJ-1O331NFV7btB-o5ap-Q68sPPy6ukni8QqKLnA0YOeJ01gVTNTClgTXCgTkOFQNVa2YqjOQqXWnIjRENaIPIhzUID5sSDM77_Ck57PoOnhEKiHIwrlIlVznPuVEN4hCmCrHMKlFDMyPZ9Fyljtzj7giMVk5JZrfS6UI6XUh3LmbJZ-Ttts8qMG_cKX3u1LWVdKzZvqFf38hoNhIEjkgZRMha8aLOhOI8X0LDTIEtwsxIPilbToWpuJTiD9k7_7rY9toz3X_2ezXZk8Q57V7UqA76cSMRhtZlVmIwPCNvgqHt3Vhs-omfQOKNMCGe_-cgXpD77ltITzwhh8N6hJcIs4blqZ9Hp36TAq8fF-d4_fxN_AWcyCgj |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLfGkAAJTTBAFDYwEuKCQhPHSRxu28RUYNuFTdrNcp3nKSMkVZscuPC38_yRqr0MiVvl2q2T9_V7id_vEfI-ZpqrMo4jECWPOEKASAiwAsFgbHKIwbgDshf57Ip_u86ud8jJWAtjj1UG3-99uvPWYWQa7uZ0UdfTHwnGrrJIGCYtcY6w-B65z9F8bRuDT3-SjeJIXw-HsyM7PVTO-ENe9W1t6UJZ4PHkW9HJkfhvBalNELpJLOqC0ekTshdQJD3yG31KdqDdJw_Ow3vyffLYP42jvsjoGamOGseebHWMdobeDD39VXsOpl7RuqWBX3VF7YNZqpwXpIuhQS1Vy9-0H-aw1EPTreqVne7abn-mii7qpuupI6l9Tq5Ov1yezKLQXyHSWcp6TB3RnnXGVAlMaWCVsGiOQ8FAlZqZAlO5QhcaUmNEBdog9GEV4sMqB4OGn74gu23XwktCAWEOJlYq5yrlKTeqQiDCVCbmSSFKqCYkGe-r1IF83PbAaOR4yuxWWllIKwtpG2PmfEI-rtcsPPXGnbOPrbjWMy1tthvoljcy6I0EgTtSBiGyVjwrE6E4T-dQMZPhiDATko7ClmNlKvpS_KH6zr_O1qu2dPef696N-iTRqO2bGtVCN6wk4tAyT3LMhifkg1e0rQsLQz_xE0i8ECbEq__cxFvycHZ5fibPvl58f00e2W_8WcUDstsvBzhEzNXP3zib-guQxihR |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alterations+of+gut+microbiota+in+patients+with+active+pulmonary+tuberculosis+in+China%3A+a+pilot+study&rft.jtitle=International+journal+of+infectious+diseases&rft.au=Shi%2C+W&rft.au=Hu%2C+Y&rft.au=Ning%2C+Z&rft.au=Xia%2C+F&rft.date=2021-10-01&rft.issn=1201-9712&rft.volume=111&rft.spage=313&rft_id=info:doi/10.1016%2Fj.ijid.2021.08.064&rft.externalDocID=oai_swepub_ki_se_459288 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1201-9712&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1201-9712&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1201-9712&client=summon |